ARTICLE | Company News
TAP Pharmaceutical withdraws NDA
June 30, 2000 7:00 AM UTC
TAP, a joint venture between Abbott (ABT) and Takeda Chemical (Osaka, Japan), withdrew its NDA for Uprima apomorphine for erectile dysfunction, which was filed in June 1999. TAP said it has additional...